ArticleFrontiers in oncology2026

Comparative efficacy and safety of individual short-acting versus long-acting granulocyte colony-stimulating factors, including biosimilars, for primary prophylaxis of chemotherapy-induced myelosuppression in breast cancer patients: a systematic review and network meta-analysis protocol.

Xiaoyun Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.